You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Ferring Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Ferring
International Patents:276
US Patents:19
Tradenames:17
Ingredients:8
NDAs:17
Patent Litigation for Ferring: See patent lawsuits for Ferring

Drugs and US Patents for Ferring

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring Pharms Inc CLENPIQ citric acid; magnesium oxide; sodium picosulfate SOLUTION;ORAL 209589-001 Nov 28, 2017 RX Yes Yes 9,827,231 ⤷  Try a Trial Y ⤷  Try a Trial
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-001 Mar 30, 1984 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Ferring Pharms Inc CERVIDIL dinoprostone INSERT, EXTENDED RELEASE;VAGINAL 020411-001 Mar 30, 1995 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Ferring CONCENTRAID desmopressin acetate SOLUTION;NASAL 019776-001 Dec 26, 1990 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Ferring DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 021795-002 May 8, 2008 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Ferring

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-001 Mar 30, 1984 5,763,407 ⤷  Try a Trial
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-001 Jun 21, 2018 8,802,624 ⤷  Try a Trial
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-001 Sep 6, 1995 5,674,850 ⤷  Try a Trial
Ferring Pharms Inc DDAVP desmopressin acetate SPRAY, METERED;NASAL 017922-002 Feb 6, 1989 5,763,407 ⤷  Try a Trial
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-001 Jun 21, 2018 9,919,025 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for FERRING drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Oral Solution 10 mg, 3.5 g, and 12 g ➤ Subscribe 2014-05-21
➤ Subscribe Oral Solution 10 mg, 3.5 g, and12 g ➤ Subscribe 2019-02-11

Supplementary Protection Certificates for Ferring Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2782584 132021000000197 Italy ⤷  Try a Trial PRODUCT NAME: ESTRADIOLO (17SS-ESTRADIOLO) IN PARTICOLARE NELLA FORMA EMIIDRATA, E PROGESTERONE COMPRENDENTI LE VARIE FORME DI ESTRADIOLO (17SS-ESTRADIOLO), QUALI LE FORME IDRATE E SOLVATATE, INCLUDENDO LA FORMA EMIIDRATA, ED I SUOI SALI.(BIJUVA); AUTHORISATION NUMBER(S) AND DATE(S): BE582231, 20210406;048335018 -048335020, 20210517
1003774 SPC/GB09/028 United Kingdom ⤷  Try a Trial PRODUCT NAME: DEGARELIX OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT SUCH AS THE ACETATE; REGISTERED: UK EU/1/08/504/001 20090217; UK EU/1/08/504/002 20090217
2782584 21C1058 France ⤷  Try a Trial PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17SS-ESTRADIOL), Y COMPRIS SOUS FORME HEMIHYDRATEE, ET DE LA PROGESTERONE; NAT. REGISTRATION NO/DATE: NL51886 20210421; FIRST REGISTRATION: BE - BE582231 20210406
1003774 PA2009005 Lithuania ⤷  Try a Trial PRODUCT NAME: DEGARELIXUM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001, 2009 02 17 EU/1/08/504/002 20090217
1003774 91585 Luxembourg ⤷  Try a Trial PRODUCT NAME: DEGARELIX, EVENTUELLEMENT UN SEL PHARMACEUTIQUEMENT ACCEPTABE, TEL QUE L'ACETATE (FIRMAGON); REG. DATE: 20090217
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.